Literature DB >> 6997950

The protection of rabbits against the herpesvirus of malignant catarrhal fever by inactivated vaccines.

N Edington, W Plowright.   

Abstract

Cell-free virulent malignant catarrhal fever virus inactivated by either formalin or acetylethylenimine (AEI) and administered with Freund's complete adjuvant protected rabbits against two consecutive parenteral challenges with cell-free virus. However 'protected' rabbits succumbed within 20 days to later inoculation of infected rabbit lymph node suspensions. Both inactivated vaccines evoked high titres of neutralising and immunofluorescent antibody, but more of the rabbits given the AEI preparation showed pyrexia after the first challenge with cell-free virus. The degree of protection afforded was compared with that induced by inactivated antigens of other herpesviruses which cause lymphoproliferative disorders

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997950

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Authors:  George C Russell; Julio Benavides; Dawn Grant; Helen Todd; David Deane; Ann Percival; Jackie Thomson; Maira Connelly; David M Haig
Journal:  Vet Res       Date:  2012-06-11       Impact factor: 3.683

Review 2.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

3.  Herpesvirus surveillance and discovery in zoo-housed ruminants.

Authors:  Teagen G Partin; Mark D Schrenzel; Josephine Braun; Carmel L Witte; Steven V Kubiski; Justin Lee; Bruce A Rideout
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

4.  Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant.

Authors:  George C Russell; David M Haig; Mark P Dagleish; Helen Todd; Ann Percival; Dawn M Grant; Jackie Thomson; Anna E Karagianni; Julio Benavides
Journal:  Vaccine X       Date:  2021-03-22

5.  The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.

Authors:  Nevi Parameswaran; George C Russell; Kathryn Bartley; Dawn M Grant; David Deane; Helen Todd; Mark P Dagleish; David M Haig
Journal:  Vet Res       Date:  2014-05-27       Impact factor: 3.683

6.  A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

Authors:  F Lankester; G C Russell; A Lugelo; A Ndabigaye; N Mnyambwa; J Keyyu; R Kazwala; D Grant; A Percival; D Deane; D M Haig; S Cleaveland
Journal:  Vaccine       Date:  2015-12-17       Impact factor: 3.641

Review 7.  Wildebeest-associated malignant catarrhal fever: perspectives for integrated control of a lymphoproliferative disease of cattle in sub-Saharan Africa.

Authors:  Lillian Wambua; Peninah Nduku Wambua; Allan Maurice Ramogo; Domnic Mijele; Moses Yongo Otiende
Journal:  Arch Virol       Date:  2015-10-08       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.